Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06333821
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-27
First Post:
2023-02-09
Brief Title:
A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma
Sponsor:
Biotech Pharmaceutical Co Ltd
Organization:
Biotech Pharmaceutical Co Ltd
Organization Data
Organization:
Biotech Pharmaceutical Co Ltd
Class:
OTHER
Study ID:
BPL-Nim-CC-3003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Biotech Pharmaceutical Co Ltd
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None